LIFECORE BIOMEDICAL INC (LFCR) — insider trading
Health Care · NASDAQ
LIFECORE BIOMEDICAL INC (LFCR) has 12 reported SEC Form 4 insider transactions in our data (latest 2026-06-04).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-04 | Kiper Christopher S; Legion Partners Asset Management, LLC; Legion Partners, L.P. I; Legion Partners, L.P. II; Legion Partners, LLC; Legion Partners Holdings, LLC; White Raymond T. | Director, 10% owner | Grant / award / vesting | 25,907 | — | — | Form 4 |
| 2026-06-04 | HOUDE LOVAS KATRINA | Director | Grant / award / vesting | 25,907 | — | — | Form 4 |
| 2026-06-04 | Johnson Paul Harold | Director | Grant / award / vesting | 25,907 | — | — | Form 4 |
| 2026-06-04 | Antunes Humberto Calheiros | Director | Grant / award / vesting | 25,907 | — | — | Form 4 |
| 2026-06-04 | Korenberg Matthew E | Director | Grant / award / vesting | 25,907 | — | — | Form 4 |
| 2026-06-04 | Schechter Joshua | Director | Grant / award / vesting | 25,907 | — | — | Form 4 |
| 2026-06-04 | Aryeh Jason | Director | Grant / award / vesting | 25,907 | — | — | Form 4 |
| 2026-06-04 | OBUS NELSON | Director | Grant / award / vesting | 25,907 | — | — | Form 4 |
| 2026-05-20 | Josephs Paul | Director, Officer (Chief Executive Officer) | Shares withheld for taxes / exercise cost | 40,413 | $4.57 | $184.7K | Form 4 |
| 2026-04-14 | Salus Thomas D. | Officer (Chief Legal & Administration) | Shares withheld for taxes / exercise cost | 24,645 | $5.20 | $128.2K | Form 4 |
| 2026-03-02 | Salus Thomas D. | Officer (Chief Legal & Administration) | Grant / award / vesting | 30,000 | — | — | Form 4 |
| 2025-09-03 | Lake Ryan David | Officer (Chief Financial Officer) | Shares withheld for taxes / exercise cost | 22,932 | $7.71 | $176.8K | Form 4 |
Ask the chat about LFCR's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: LIFECORE BIOMEDICAL INC (LFCR).
Last updated 2026-06-04 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.